CONSUN PHARMA(01681)

14.850+0.120+0.81%

CommunityCommunity
NewsNews
ProfileProfile
AnnouncementsAnnouncements

- CONSUN PHARMA: FMR LLC Acquires Shares, Long Position Rises to 9%
  HK Disclosure · 10-08 17:25
  CONSUN PHARMA: FMR LLC Acquires Shares, Long Position Rises to 9%
- CONSUN PHARMA: FMR LLC Disposes of Shares, Long Position Falls to 8.99%
  HK Disclosure · 10-07
  CONSUN PHARMA: FMR LLC Disposes of Shares, Long Position Falls to 8.99%
- Consun Pharma Cuts Outstanding Shares by 1.11 Million in September 2026 on HKD 16.45 Million Buybacks
  Bulletin Express · 10-05
  Consun Pharma Cuts Outstanding Shares by 1.11 Million in September 2026 on HKD 16.45 Million Buybacks
- FMR LLC Raises Stake in CONSUN PHARMA with Purchase of 116,000 Shares at About HK$14.42 Each
  Stock News · 09-29
  FMR LLC Raises Stake in CONSUN PHARMA with Purchase of 116,000 Shares at About HK$14.42 Each
- CONSUN PHARMA: FMR LLC Acquires Shares, Long Position Rises to 9.0%
  HK Disclosure · 09-29
  CONSUN PHARMA: FMR LLC Acquires Shares, Long Position Rises to 9.0%
- Everbright Securities Reiterates "Buy" on Consun Pharma (01681) as Renal Business Delivers Strong Growth
  Stock News · 09-29
  Everbright Securities Reiterates "Buy" on Consun Pharma (01681) as Renal Business Delivers Strong Growth
- CONSUN PHARMA Publishes 2026 Interim Report and Adopts Full e-Communication Regime
  Bulletin Express · 09-24
  CONSUN PHARMA Publishes 2026 Interim Report and Adopts Full e-Communication Regime
- Consun Pharmaceutical Announces Online Publication of 2026 Interim Report and Moves to Fully Electronic Corporate Communications
  Bulletin Express · 09-24
  Consun Pharmaceutical Announces Online Publication of 2026 Interim Report and Moves to Fully Electronic Corporate Communications
- Unveiling the Long-Term Potential of CONSUN PHARMA (01681): A Renal Care Leader Strengthening Its Growth Foundation Through Diversified Innovation
  Stock News · 09-18
  Unveiling the Long-Term Potential of CONSUN PHARMA (01681): A Renal Care Leader Strengthening Its Growth Foundation Through Diversified Innovation
- Consun Pharma Repurchases 50,000 Shares; Treasury Stock Rises to 3.75 Million
  Bulletin Express · 09-17
  Consun Pharma Repurchases 50,000 Shares; Treasury Stock Rises to 3.75 Million
- CONSUN PHARMA Allocates HK$2.528 Million for Share Buyback on September 16
  Stock News · 09-16
  CONSUN PHARMA Allocates HK$2.528 Million for Share Buyback on September 16
- CONSUN PHARMA Spends HKD 2.53 Million to Buy Back 193,000 Shares, Lifts Treasury Stock to 3.70 Million
  Bulletin Express · 09-16
  CONSUN PHARMA Spends HKD 2.53 Million to Buy Back 193,000 Shares, Lifts Treasury Stock to 3.70 Million
- Pharmaceutical Firm Completes Share Buyback Valued at Roughly 4 Million Hong Kong Dollars
  Stock News · 09-15
  Pharmaceutical Firm Completes Share Buyback Valued at Roughly 4 Million Hong Kong Dollars
- Consun Pharma Repurchases 406,000 Shares; Treasury Stock Rises to 3.21 Million
  Bulletin Express · 09-11
  Consun Pharma Repurchases 406,000 Shares; Treasury Stock Rises to 3.21 Million
- Consun Pharma Buys Back 305,000 Shares for HKD 4.00 Million, Boosting Treasury Stock to 2.80 Million
  Bulletin Express · 09-10
  Consun Pharma Buys Back 305,000 Shares for HKD 4.00 Million, Boosting Treasury Stock to 2.80 Million
- Consun Pharma Allocates HK$4 Million to Repurchase 305,000 Shares on September 10
  Stock News · 09-10
  Consun Pharma Allocates HK$4 Million to Repurchase 305,000 Shares on September 10
- Consun Pharma Files HKEX Next-Day Disclosure Return After Share Repurchase for Treasury Shares
  Reuters · 09-10
  Consun Pharma Files HKEX Next-Day Disclosure Return After Share Repurchase for Treasury Shares
- Consun Pharmaceutical Group (SEHK:1681) Lifts Earnings And Dividend On A Valuation That Still Looks Cheap
  Simply Wall St. · 09-03
  Consun Pharmaceutical Group (SEHK:1681) Lifts Earnings And Dividend On A Valuation That Still Looks Cheap
- Consun Pharma Maintains Stable Share Capital in August 2026 Monthly Return
  Bulletin Express · 09-01
  Consun Pharma Maintains Stable Share Capital in August 2026 Monthly Return
- Consun Pharmaceutical Group And 2 Other Undiscovered Gems In Asia
  Simply Wall St. · 08-31
  Consun Pharmaceutical Group And 2 Other Undiscovered Gems In Asia
Company Profile
Company Name
CONSUN PHARMA
Market
SEHK
Establishment Date
- -
Employees
- -
Office Location
- -
Website
http://www.chinaconsun.com
Zip Code
- -
Phone
- -
Fax
- -
Introduction
Consun Pharmaceutical Group Ltd is a company principally engaged in manufacturing and sales of pharmaceutical products. The Company operates its businesses through two segments. Consun Pharmaceutical segment is mainly engaged in manufacturing and sells of modern Chinese medicines and medical contrast medium. Yulin Pharmaceutical segment is mainly involved in manufacturing and sells of traditional Chinese medicines. The Company's products include kidney medicines, gynaecology and paediatrics medicines, contrast medium, orthopedics medicines, dermatologic medicines, hepatobiliary medicines and others. The Company mainly operates its businesses in the domestic market.
- 09-24
  Interim Report
  INTERIM REPORT 2026
  INTERIM REPORT 2026
- 08-26
  Interim Report
  INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED 30 JUNE 2026
  INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED 30 JUNE 2026
- 04-28
  Annual Report
  ANNUAL REPORT 2025
  ANNUAL REPORT 2025

1D
5D
Day
Week
Month

Loading ...

High

14.970

Open

14.690

Volume%

0.78

Low

14.520

14.730

T/O Rate

0.12%

To The Moon

CONSUN PHARMA(01681)

Company Profile

Most Discussed